Medical Devices: Page 5
-
Remote patient monitoring in Medicare needs more oversight: OIG
Regulators say Medicare needs more data and oversight to avoid fraud and misuse. Digital health advocates argue the service is still crucial for managing chronic conditions.
By Emily Olsen • Sept. 27, 2024 -
Mendaera raises $73M to develop handheld robotics platform
Fred Moll, founder of surgical robotics firms Intuitive Surgical and Auris Health, participated in in the financing round, along with previous Auris investors.
By Nick Paul Taylor • Sept. 27, 2024 -
Trendline
Medical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Lawmakers call for investigation of former FDA device director
The letter to the health department watchdog follows a New York Times report that raised concerns about Jeff Shuren’s potential conflicts of interest as head of the FDA’s device center.
By Elise Reuter • Sept. 26, 2024 -
FDA proposes reclassifying hepatitis B assays
The FDA plans to move the assays from higher-risk class III devices to class II, making them eligible for the 510(k) pathway.
By Nick Paul Taylor • Sept. 26, 2024 -
Medtronic, Siemens Healthineers partner on spine surgery
Siemens Healthineers will integrate its robotic X-ray imaging system with Medtronic’s spine surgery suite.
By Elise Reuter • Sept. 25, 2024 -
Masimo CEO, founder Kiani resigns
Michelle Brennan was named acting CEO of the patient monitoring company following Joe Kiani’s defeat in a proxy battle with an activist investor.
By Susan Kelly • Sept. 25, 2024 -
FDA names new head of medical device evaluation and quality
Ross Segan was chosen to lead the office, which handles premarket authorizations and recalls, in the agency’s Center for Devices and Radiological Health.
By Susan Kelly • Sept. 24, 2024 -
Recalled heart devices had limited clinical testing, study finds
Just 30 of 157 heart devices with Class I recalls underwent premarket clinical testing, according to a study published in the Annals of Internal Medicine.
By Elise Reuter • Sept. 24, 2024 -
Route 92 Medical raises $50M to fund global sales of stroke devices
The latest investment extends an earlier funding round, bringing the total raised to $82 million. Novo Holdings, the controlling shareholder of Novo Nordisk, joined returning investors.
By Nick Paul Taylor • Sept. 24, 2024 -
Stryker adds devices to remove brain tumors, clots with Nico buy
Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.
By Nick Paul Taylor • Sept. 23, 2024 -
FDA posts draft guidance on biocompatibility testing of devices
To promote consistency and reliability in premarket submissions, the FDA shared approaches for device biocompatibility analysis.
By Nick Paul Taylor • Sept. 23, 2024 -
Deep Dive
4 steps to minimize the threat of legacy medical devices
Older medical devices with unsupported software pose cybersecurity threats that regulators and industry are struggling to solve. Here are four steps experts say can help mitigate risks.
By Ricky Zipp • Sept. 23, 2024 -
Abbott ramps up Libre 3 production amid shortages
Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.
By Elise Reuter • Sept. 20, 2024 -
Masimo investor claims proxy war win as CEO Kiani fails to retain board seat
Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.
By Susan Kelly • Sept. 20, 2024 -
Jury sides with Axonics in Medtronic patent dispute
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
By Elise Reuter • Sept. 19, 2024 -
Masimo proxy fight nears end as shareholder vote looms
Chairman and CEO Joe Kiani’s board seat is on the line at today's shareholder meeting.
By Susan Kelly • Sept. 19, 2024 -
Zimmer pulls hip implant off the market due to fracture risk
The company plans to phase out use of its CPT Hip System by December, but the FDA is still concerned about implants in new patients.
By Elise Reuter • Sept. 18, 2024 -
Merit Medical inks $210M takeover of Cook’s lead management business
Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.
By Nick Paul Taylor • Sept. 18, 2024 -
Senseonics receives FDA clearance for one-year CGM
Commercial partner Ascensia is in discussions with insulin pump manufacturers to create an automated insulin delivery system.
By Elise Reuter • Sept. 17, 2024 -
Synchron connects brain-computer interface tech to Amazon Alexa
The patient can use the implant to turn on lights, make video calls, play music and shows, read books and buy products online without using their hands or voice.
By Nick Paul Taylor • Sept. 17, 2024 -
Smiths Medical recalls airway tubes over defect linked to more than 10 injuries
Smiths has had seven Class I recalls, the most severe kind, so far in 2024.
By Elise Reuter • Sept. 16, 2024 -
Bausch + Lomb considers sale: FT
Private equity could be “the most likely” buyer of the eye care business, analysts wrote.
By Elise Reuter • Sept. 16, 2024 -
Apple wins FDA nod for hearing aid software for certain Airpods
Apple is the first company to receive authorization for over-the-counter hearing aid software.
By Nick Paul Taylor • Sept. 13, 2024 -
Roche to launch new CGM in Europe in ‘coming weeks’
Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.
By Elise Reuter • Sept. 12, 2024 -
SS Innovations expects US OK for surgical robot in 2025
The robot maker plans to conduct clinical trials for several indications, including abdominal, pelvic, thoracic and cardiac procedures.
By Susan Kelly • Sept. 12, 2024